BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 23985307)

  • 21. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1.
    Chan EH; Nousiainen M; Chalamalasetty RB; Schäfer A; Nigg EA; Silljé HH
    Oncogene; 2005 Mar; 24(12):2076-86. PubMed ID: 15688006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
    Irie K; Nagai T; Mizuno K
    J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of Protein Interactions by
    Xiong S; Couzens AL; Kean MJ; Mao DY; Guettler S; Kurinov I; Gingras AC; Sicheri F
    Mol Cell Proteomics; 2017 Jun; 16(6):1111-1125. PubMed ID: 28373297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hippo signaling is intrinsically regulated during cell cycle progression by APC/C
    Kim W; Cho YS; Wang X; Park O; Ma X; Kim H; Gan W; Jho EH; Cha B; Jeung YJ; Zhang L; Gao B; Wei W; Jiang J; Chung KS; Yang Y
    Proc Natl Acad Sci U S A; 2019 May; 116(19):9423-9432. PubMed ID: 31000600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Hippo Pathway: Biology and Pathophysiology.
    Ma S; Meng Z; Chen R; Guan KL
    Annu Rev Biochem; 2019 Jun; 88():577-604. PubMed ID: 30566373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.
    Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL
    Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP.
    Huang J; Wu S; Barrera J; Matthews K; Pan D
    Cell; 2005 Aug; 122(3):421-34. PubMed ID: 16096061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The functions of the Hippo signaling pathway in immune cells.
    Yu SJ; Geng J; Chen LF
    Yi Chuan; 2017 Jul; 39(7):650-658. PubMed ID: 28757479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. POPX2 is a novel LATS phosphatase that regulates the Hippo pathway.
    Rahmat MB; Zhang S; Koh CG
    Oncotarget; 2019 Feb; 10(15):1525-1538. PubMed ID: 30863499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arsenic-induced cutaneous hyperplastic lesions are associated with the dysregulation of Yap, a Hippo signaling-related protein.
    Li C; Srivastava RK; Elmets CA; Afaq F; Athar M
    Biochem Biophys Res Commun; 2013 Sep; 438(4):607-12. PubMed ID: 23942117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-canonical Hippo signaling regulates immune responses.
    Chen L
    Adv Immunol; 2019; 144():87-119. PubMed ID: 31699221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling.
    Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A
    Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Hippo pathway in intestinal regeneration and disease.
    Hong AW; Meng Z; Guan KL
    Nat Rev Gastroenterol Hepatol; 2016 Jun; 13(6):324-37. PubMed ID: 27147489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion.
    Nouri K; Azad T; Lightbody E; Khanal P; Nicol CJ; Yang X
    FASEB J; 2019 Nov; 33(11):12487-12499. PubMed ID: 31431076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis.
    Zinatizadeh MR; Miri SR; Zarandi PK; Chalbatani GM; Rapôso C; Mirzaei HR; Akbari ME; Mahmoodzadeh H
    Genes Dis; 2021 Jan; 8(1):48-60. PubMed ID: 33569513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hippo signalling in the G2/M cell cycle phase: lessons learned from the yeast MEN and SIN pathways.
    Hergovich A; Hemmings BA
    Semin Cell Dev Biol; 2012 Sep; 23(7):794-802. PubMed ID: 22525225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Hippo signaling pathway in liver regeneration and tumorigenesis.
    Hong L; Cai Y; Jiang M; Zhou D; Chen L
    Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):46-52. PubMed ID: 25476204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The NDR family of kinases: essential regulators of aging.
    Jonischkies K; Del Angel M; Demiray YE; Loaiza Zambrano A; Stork O
    Front Mol Neurosci; 2024; 17():1371086. PubMed ID: 38803357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic Fluctuations in Subcellular Localization of the Hippo Pathway Effector Yorkie In Vivo.
    Manning SA; Dent LG; Kondo S; Zhao ZW; Plachta N; Harvey KF
    Curr Biol; 2018 May; 28(10):1651-1660.e4. PubMed ID: 29754899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MOB: Pivotal Conserved Proteins in Cytokinesis, Cell Architecture and Tissue Homeostasis.
    Delgado ILS; Carmona B; Nolasco S; Santos D; Leitão A; Soares H
    Biology (Basel); 2020 Nov; 9(12):. PubMed ID: 33255245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.